Novo Nordisk CEO to testify before Senate on weight loss drug prices

Lars Fruergaard Jørgensen, CEO of Novo Nordisk, speaks during an interview in New York on August 10, 2022. Christopher Goodney…

Novartis CEO says it won't join weight-loss drug frenzy

The CEO of Novartis The Swiss pharmaceutical giant has no intention of getting into the “frenzy” of weight loss drugs,…